Clinical trial
Clinical Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Ulcerative Colitis
NCT05986136 is registered in ClinicalTrials.gov with Mostafa Bahaa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Ulcerative Colitis
- Lead sponsor
- Mostafa Bahaa
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 20, 2023
- Completion date
- August 20, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.